Iannis Aifantis

NYU Langone Health — United States

Medicine · Health Sciences

90h-index26.5kcitations451works0.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Myeloid Leukemia Research(106), RNA Research and Splicing(56), Immune Cell Function and Interaction(53), Epigenetics and DNA Methylation(51), Cancer-related molecular mechanisms research(49)

Publications449 total

The integrated stress response promotes immune evasion through lipocalin 2
Nature·2026
Type-2-immune history imprints local training in nerve-airway associated interstitial macrophages (NAMs) for disease tolerance during respiratory viral infection
2026Open Access
(Sub)Clonal Wars: Interferon Interference Yields the Upper Hand
Blood Cancer Discovery·2025
Supplementary Table S1 from Mitophagy Promotes Resistance to BH3 Mimetics in Acute Myeloid Leukemia
2025Open Access
Supplementary Table S4 from Mitophagy Promotes Resistance to BH3 Mimetics in Acute Myeloid Leukemia
2025Open Access
Supplementary Table S3 from Mitophagy Promotes Resistance to BH3 Mimetics in Acute Myeloid Leukemia
2025Open Access
Supplementary Table S2 from Mitophagy Promotes Resistance to BH3 Mimetics in Acute Myeloid Leukemia
2025Open Access
Supplementary Table S5 from Mitophagy Promotes Resistance to BH3 Mimetics in Acute Myeloid Leukemia
2025Open Access
Supplementary Methods from Mitophagy Promotes Resistance to BH3 Mimetics in Acute Myeloid Leukemia
2025Open Access
Supplementary Figures 1-7 from Mitophagy Promotes Resistance to BH3 Mimetics in Acute Myeloid Leukemia
2025Open Access
Multiomic characterization, early detection, and therapeutic targeting of myeloid sarcoma
2025Open Access
Exploiting RAS pathway addiction as a therapeutic vulnerability in myeloid sarcoma
Blood·2025
Non-coding variants in UBA1 lead to vexas
Blood·2025Open Access
Epigenetic reactivation of a tumor suppressor program in AML.
Blood·2025Open Access
Small-molecule OPA1 inhibitors reverse mitochondrial adaptations to overcome therapy resistance in acute myeloid leukemia
Science Advances·2025· 3 citedOpen Access
Publisher Correction: The pre-T cell receptor as a tumor immunotherapy target in T cell leukemia
Nature Immunology·2025Open Access
The pre-T cell receptor as a tumor immunotherapy target in T cell leukemia
Nature Immunology·2025
Figure 2 from Uncovering Novel lncRNAs Linked to Melanoma Growth and Migration with CRISPR Inhibition Screening
2025Open Access
Figure 3 from Uncovering Novel lncRNAs Linked to Melanoma Growth and Migration with CRISPR Inhibition Screening
2025Open Access
Table S2 from Uncovering Novel lncRNAs Linked to Melanoma Growth and Migration with CRISPR Inhibition Screening
2025Open Access
page 1 of 23Next →

Frequent Co-authors

Aristotelis Tsirigos(11), Thomas Trimarchi(11), Omar Abdel‐Wahab(10), Ross L. Levine(10), Adolfo A. Ferrando(9), Camille Lobry(8), Panagiotis Ntziachristos(8), Alan H. Shih(6), Silvia Buonamici(6), Elisabeth Paietta(6), Delphine Ndiaye‐Lobry(5), Sofia Bakogianni(5), Bryan H. King(5), Xinyang Zhao(4), Suveg Pandey(4), Stephen D. Nimer(4), Ari Melnick(4), Anastasia N. Tikhonova(4), Igor Dolgalev(4), Xufeng Chen(4)